Healthcare products company CCA Industries Inc (OTC:CAWW) disclosed on Monday that its income amounted to USD349,320 for the second quarter ended 31 May 2019.
This marks an improvement when compared with a loss of USD292,320 for the same period in fiscal 2018.
Revenues of USD5.458m were generated for the three months ended 31 May 2019,up over revenues of USD4.225m for the comparable period in fiscal 2018.
EBITDA of USD574,176 were recorded for the second quarter ended 31 May 2019, a rise from EBITDA of USD231,136 for the corresponding period in fiscal 2018.
TridentUSA Health Services signs products & services agreement with Consulate Health Care
Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma
Antiviral Compounds Developer ReViral Names Sapir as Chief Executive Officer
Merck's board approves USD0.55 per share dividend for Q3 2019
Medicure swings to net loss of USD2.8m for Q1 2019
Bexion Pharmaceuticals names new director
Selvita incurs higher net loss of USD2.2m in Q1 2019